Schedule 13G ownership disclosure

ADAPTIMMUNE THERAPEUTICS PLC

Security class unavailable · CUSIP: 00653A107

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
102,618,552
Percent of class
10.4400%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001088875-22-000130
Form type
SC 13G/A
Filer
Adaptimmune Therapeutics PLC
CIK
CIK 1621227
Filed
Dec 02, 2022
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub